Work

Novel agents in second-line therapy for EGFR wild-type Advanced Non-Small-Cell Lung Cancer.

Year: 2016

Type: article

Source: PubMed

Authors: L El Amarti, I Elghissassi, M Layachi, H Mrabti, H Errihani

Institutions: Mohammed V University, Institut National d'Oncologie

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2409123225

FWCI: 0.246

Cites:

Cited by: 1

Related to: 10